Mostrando 2 resultados de: 2
Pharmacologic treatment of obesity: Pitfalls and new promises
ReviewAbstract: Obesity is a chronic, stigmatized and costly disease with increasing prevalence acquiring pandemic pPalabras claves:body mass index, Energetic balance, Noradrenergic agents, obesity, Orlistat, Serotoninergic agents, SibutramineAutores:Ciszek A., Colmenares C., González M.C., Gotera D., Guerra-Torres X.E., Luti Y., Nuñez M., Rodriguez M., Rojas-Quintero J., Urdaneta I., Valdelamar L., Valmore Bermúdez, Velasco M.Fuentes:scopusLipoprotein(a): From molecules to therapeutics
ReviewAbstract: Lipoprotein (a) [Lp(a)] was discovered by Kare Berg in 1963 from the study of low-density lipoproteiPalabras claves:Atherogenesis, Cardiovascular disease, Hyperlipoproteinemia(a), lipoprotein(a), therapeuticsAutores:Amell A., Aparicio D., Arráiz N., Cabrera M., Canelón R., Cano R.A., Cano-Ponce C., Faria J., Gotera D., Guerra-Torres X.E., Mengual-Moreno E., Reyna-Villasmil N., Rojas E.R., Sorell L.T., Valmore Bermúdez, Velasco M.Fuentes:scopus